Vacuolar (H+)-ATPase Critically Regulates Specialized Proresolving Mediator Pathways in Human M2-like Monocyte-Derived Macrophages and Has a Crucial Role in Resolution of Inflammation
暂无分享,去创建一个
O. Werz | C. Serhan | A. Rossi | T. Kamradt | S. Pace | D. Menche | F. Troisi | J. Gerstmeier | N. Andreas | P. M. Jordan | Rossella Bilancia | Zhigang Rao | Friedemann Börner
[1] C. Serhan,et al. Aging Delays Resolution of Acute Inflammation in Mice: Reprogramming the Host Response with Novel Nano-Proresolving Medicines , 2014, The Journal of Immunology.
[2] Wolfgang Albrecht,et al. Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor. , 2012, Nature chemical biology.
[3] R. Murphy,et al. Dual 12/15- and 5-Lipoxygenase Deficiency in Macrophages Alters Arachidonic Acid Metabolism and Attenuates Peritonitis and Atherosclerosis in ApoE Knock-out Mice* , 2009, The Journal of Biological Chemistry.
[4] R. Sundler,et al. Bafilomycin A1 inhibits lysosomal, phagosomal, and plasma membrane H+‐ATPase and induces lysosomal enzyme secretion in macrophages , 1995, Journal of cellular physiology.
[5] J. O’Shea,et al. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor , 2003, Science.
[6] M. Simons,et al. Vacuolar ATPase is required for ERK‐dependent wound healing in the Drosophila embryo , 2018, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[7] E. Jaffe,et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. , 2008, Blood.
[8] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[9] M. Forgac,et al. Recent Insights into the Structure, Regulation, and Function of the V-ATPases. , 2015, Trends in biochemical sciences.
[10] C. Serhan,et al. Pro-Resolving Mediators in Regulating and Conferring Macrophage Function , 2017, Front. Immunol..
[11] O. Werz,et al. 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. , 2015, Biochimica et biophysica acta.
[12] G. Feldman,et al. Monocyte 15-Lipoxygenase Expression Is Regulated by a Novel Cytosolic Signaling Complex with Protein Kinase C δ and Tyrosine-Phosphorylated Stat31 , 2006, The Journal of Immunology.
[13] M. Landthaler,et al. Luminescent Dual Sensors Reveal Extracellular pH-Gradients and Hypoxia on Chronic Wounds That Disrupt Epidermal Repair , 2014, Theranostics.
[14] M. Zaiss,et al. The double-edged role of 12/15-lipoxygenase during inflammation and immunity. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[15] A. Gilman‐Sachs,et al. Tumor-Associated a2 Vacuolar ATPase Acts As a Key Mediator of Cancer-Related Inflammation by Inducing Pro-Tumorigenic Properties in Monocytes , 2011, The Journal of Immunology.
[16] Dudley Lamming,et al. Akt-mTORC1 signaling regulates Acly to integrate metabolic input to control of macrophage activation , 2016, eLife.
[17] D. Ito,et al. Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals , 2016, Nature Communications.
[18] P. Isakson,et al. In vivo characterization of zymosan-induced mouse peritoneal inflammation. , 1994, The Journal of pharmacology and experimental therapeutics.
[19] D. Gilroy,et al. CYP450-derived oxylipins mediate inflammatory resolution , 2016, Proceedings of the National Academy of Sciences.
[20] Y. Dou,et al. Epigenetic regulation of the alternatively activated macrophage phenotype. , 2009, Blood.
[21] P. Murray. Macrophage Polarization. , 2017, Annual review of physiology.
[22] J. Benveniste,et al. Formation of prostaglandins, leukotrienes and paf-acether by macrophages. , 1985, Comparative immunology, microbiology and infectious diseases.
[23] C. Serhan,et al. Resolution phase lipid mediators of inflammation: agonists of resolution. , 2013, Current opinion in pharmacology.
[24] O. Werz,et al. Selective upregulation of TNF&agr; expression in classically‐activated human monocyte‐derived macrophages (M1) through pharmacological interference with V‐ATPase , 2017, Biochemical pharmacology.
[25] S. Kundu,et al. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. , 2013, Free radical biology & medicine.
[26] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[27] H. Claésson,et al. Mice lacking 12/15-lipoxygenase have attenuated airway allergic inflammation and remodeling. , 2008, American journal of respiratory cell and molecular biology.
[28] Charles N. Serhan,et al. Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.
[29] Ji-Yun Kim,et al. Activation of PI3K, Akt, and ERK during early rotavirus infection leads to V-ATPase-dependent endosomal acidification required for uncoating , 2018, PLoS pathogens.
[30] D. Gilroy,et al. Macrophage development and polarization in chronic inflammation. , 2015, Seminars in immunology.
[31] S. Grinstein,et al. Contrasting phagosome pH regulation and maturation in human M1 and M2 macrophages , 2014, Molecular biology of the cell.
[32] William B. Smith,et al. Selective inhibition of BET bromodomains , 2010, Nature.
[33] O. Werz,et al. ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma , 2008, Proceedings of the National Academy of Sciences.
[34] Bjarni V. Halldórsson,et al. A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis , 2019, Nature Genetics.
[35] C. Serhan,et al. Novel proresolving and tissue‐regenerative resolvin and protectin sulfido‐conjugated pathways , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[37] A. Haque,et al. Bactericidal Activity of Alveolar Macrophages is Suppressed by V-ATPase Inhibition , 2014, Lung.
[38] C. Serhan,et al. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics. , 2017, Prostaglandins, leukotrienes, and essential fatty acids.
[39] C. Serhan,et al. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. , 2012, Blood.
[40] D. Conrad,et al. Regulation of human 12/15-lipoxygenase by Stat6-dependent transcription. , 2000, American journal of respiratory cell and molecular biology.
[41] S. Grinstein,et al. V-ATPases in phagocytic cells. , 1992, The Journal of experimental biology.
[42] H. Reichenbach,et al. Archazolids, new cytotoxic macrolactones from Archangium gephyra (Myxobacteria). Production, isolation, physico-chemical and biological properties. , 2003, The Journal of antibiotics.
[43] A. Vollmar,et al. Anti-leukemic effects of the V-ATPase inhibitor Archazolid A , 2015, Oncotarget.
[44] G. Feldman,et al. Monocyte 15-Lipoxygenase Gene Expression Requires ERK1/2 MAPK Activity , 2010, The Journal of Immunology.
[45] C. Serhan,et al. Macrophage Proresolving Mediators-the When and Where. , 2016, Microbiology spectrum.
[46] O. Werz,et al. Human macrophages differentially produce specific resolvin or leukotriene signals that depend on bacterial pathogenicity , 2018, Nature Communications.
[47] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[48] G. Evan,et al. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. , 2012, Blood.